Effects of clomipramine on sleep EEG and nocturnal penile tumescence: a long-term study in a healthy man.

J Clin Psychopharmacol

Department of Psychiatry, University of Mainz, Federal Republic of Germany.

Published: October 1988

The effects of the tricyclic antidepressant clomipramine on sleep EEG and nocturnal penile tumescence (NPT) were investigated during a long-term study in a normal male control subject. During 21 consecutive days the subject received first placebo for 3 days, then stepwise increasing dosages of clomipramine for 10 days, and finally placebo after withdrawal for 8 days. Under clomipramine, rapid eye movement (REM) sleep was suppressed markedly; an REM rebound occurred after withdrawal. Awake and stages 1 and 2 increased while slow wave sleep was diminished under clomipramine. Those non-REM parameters returned to baseline values after drug cessation. NPT was reduced simultaneously with REM sleep under clomipramine 30 to 75 mg. Under this dosage range, full erections occurred during the later hours of sleep in association with the delayed REM periods. Clomipramine 100 mg prompted a further decrease of NPT, which exceeded the REM suppression. Most of the changes and NPT parameters depended significantly on the dosage and the plasma concentration of clomipramine. After withdrawal, NPT needed 6 days to normalize. Although NPT was disturbed distinctly, no erectile dysfunction, but a decrease of sexual interest and, once, a lack of ejaculation, were reported.

Download full-text PDF

Source

Publication Analysis

Top Keywords

clomipramine sleep
8
sleep eeg
8
eeg nocturnal
8
nocturnal penile
8
penile tumescence
8
long-term study
8
rem sleep
8
clomipramine
7
sleep
6
npt
6

Similar Publications

Article Synopsis
  • Previous randomized controlled trials have largely shown that antidepressants do not provide significant benefits for restricted and repetitive behaviors (RRBs) in individuals with autism spectrum disorder (ASD).
  • A systematic review of nine trials involving 609 participants found no notable differences in RRB outcomes between those treated with antidepressants and those given a placebo.
  • Only specific antidepressants like clomipramine and fluvoxamine showed some positive effects in small preliminary studies, but these findings need to be verified in larger trials.
View Article and Find Full Text PDF

In persons with narcolepsy type 1, sudden withdrawal of antidepressants can cause status cataplecticus. We describe a 77-year-old female patient with long-standing history of narcolepsy type 1 complaining of recurrent short sudden episodes of whole-body paralysis, with preserved consciousness and memory. Episodes started an hour after her family invited her to celebrate Mother's Day.

View Article and Find Full Text PDF

Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review.

Eur J Investig Health Psychol Educ

August 2023

Facultad de Ciencias Jurídicas y Sociales, Universidad Simón Bolívar, Cúcuta 540001, Colombia.

This review aimed to investigate the metabolic alterations associated with psychopharmacological treatment of neuropsychiatric disorders, which can significantly impact patients' physical health and overall quality of life. The study utilized the PRISMA methodology and included cross-sectional, retrospective studies, and randomized clinical trials from reputable databases like SCOPUS, CLARIVATE, SCIENCE DIRECT, and PUBMED. Out of the 64 selected studies, various psychotropic drug classes were analyzed, including antidepressants, anticonvulsants, and antipsychotics.

View Article and Find Full Text PDF

Psychotic Disorder as the First Manifestation of Addison Disease: A Case Report.

Int J Endocrinol Metab

January 2022

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institude, Shariati Hospital, Tehran University of Medical Sciences,Tehran, Iran.

Introduction: Addison disease is a relatively uncommon endocrine disease resulting from adrenal insufficiency. Psychiatric symptoms are among its rare primary and particularly isolated clinical symptoms. This report presents a case with adrenal insufficiency manifested by the psychotic syndrome.

View Article and Find Full Text PDF

A 57-year-old man presented with difficulty speaking and walking along with increased daytime somnolence. His symptoms fluctuated throughout the day but never completely disappeared. A neurological examination revealed mild dysarthria, limb weakness, and staggering gait.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!